Pharmaceutical

Filter

Current filters:

None

Popular Filters

6626 to 6650 of 7218 results

US FDA approves Erbitux as first-line treatment in KRAS wild-type EGFR

09-07-2012

US drug majors Eli Lilly (NYSE: LLY) and Bristol-Myers Squibb (NYSE: BMY) on Friday received full approval…

Bristol-Myers SquibbEli LillyErbituxNorth AmericaOncologyPharmaceuticalQiagenRegulation

Sucampo fails in Amitiza arbitration with Takeda

09-07-2012

US drugmaker Sucampo Pharmaceuticals (Nasdaq: SCMP) says that it has received a final binding decision…

AmitizaLegalLicensingPharmaceuticalResculaSucampoTakeda Pharmaceuticals

Novartis Indian Supreme Court hearings again re-scheduled

09-07-2012

Humanitarian aid agency Medecins Sans Frontieres said on Friday it has learnt that final arguments in…

Asia-PacificGenericsGleevecGlivecLegalNovartisPatentsPharmaceutical

FDA sets PDUFA date for Alexza's resubmission for Adasuve

08-07-2012

Following two earlier rejections, the US Food and Drug Administration has now accepted Alexza Pharmaceuticals…

AdasuveAlexza PharmaceuticalFerrer InternacionalNeurologicalNorth AmericaPharmaceuticalRegulation

UCB's Vimpat effective in achieving seizure control in patients with refractory epilepsy

08-07-2012

Results published in the June online edition of Seizure from an independent multicenter study covering…

NeurologicalPharmaceuticalResearchUCBVimpat

Eli Lilly gains six months US pediatric exclusivity for Cymbalta

08-07-2012

US drug major Eli Lilly (NYSE: LLY) announced that it has met the US Food and Drug Administration requirements…

CymbaltaEli LillyNeurologicalNorth AmericaPharmaceuticalRegulation

Diabetes drug metformin makes brain cells grow

08-07-2012

The widely used diabetes drug metformin comes with a rather unexpected and alluring side effect: it encourages…

DiabetesNeurologicalPharmaceuticalResearch

Australian pharma companies to disclose payments to doctors under new Code of Conduct

06-07-2012

Australian pharma trade group Medicines Australia says that its new Code of Conduct will require member…

Asia-PacificMarkets & MarketingPharmaceuticalRegulation

NICE draft guidance continues negative on Roche's Avastin for metastatic breast cancer

06-07-2012

Final draft guidance published today (July 6) by the UK's drugs watchdog the National Institute for Health…

AvastinEuropeOncologyPharmaceuticalPricingRegulationRoche

Russia's ChemRar gets rights to Pfizer's DPP-IVi diabetes candidate

06-07-2012

Russia's ChemRar Hi-Tech Centre, a pharmaceutical investment and R&D group, said yesterday that global…

ChemRar Hi-TechDiabetesLicensingPfizerPharmaceuticalSatRx

Bilthoven Biologicals acquired by Serum Institute of India

06-07-2012

Bilthoven Biologicals, a Dutch manufacturer of monoclonal antibodies and vaccines, said this week that…

Bilthoven BiologicalsBiotechnologyMergers & AcquisitionsPharmaceuticalSerum Institute of IndiaVaccines

New Zealand agrees to fund Iressa but amends Tarceva use

05-07-2012

New Zealand's pharmaceutical management agency PHARMAC has approved the proposal to fund AstraZeneca's…

Asia-PacificAstraZenecaIressaOncologyPharmaceuticalPricingRegulationRocheTarceva

Novartis and Teva announce expansion plans in Russia

05-07-2012

Swiss drug major Novartis (NOVN: VX) has signed an agreement with RT-Biotechprom, one of Russia's largest…

EuropeFinancialGenericsMarkets & MarketingNovartisPharmaceuticalRT-BiotechpromTeva Pharmaceutical Industries

EMA's next steps for maintenance of information on medicines

05-07-2012

The European Medicines Agency is providing pharmaceutical companies with information on the next steps…

EuropePharmaceuticalRegulation

Platelet drug shows clinical benefits for severe, unresponsive aplastic anemia

05-07-2012

Eltrombopag, a drug that was designed to stimulate production of platelets from the bone marrow and thereby…

GlaxoSmithKlinePharmaceuticalRare diseasesResearch

Managing the impact of patent protection loss for Big Pharma

05-07-2012

Exclusivity is everything in the pharmaceutical brand business. Without it, power over pricing disappears…

Markets & MarketingPatentsPharmaceuticalPricing

EU Parliament rejects ACTA by massive 478 vote from MEPs

05-07-2012

The controversial Anti-Counterfeiting Trade Agreement (ACTA) was rejected by the European Parliament…

EuropePatentsPharmaceuticalPoliticsRegulation

Germany's IQWiG finds no proof of added benefit for AstraZeneca's Caprelsa in thyroid cancer

05-07-2012

The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined the added benefit…

AstraZenecaCaprelsaEuropeOncologyPharmaceuticalPricingRegulation

Johnson & Johnson pulls EU submission for Velcade use in NHL

05-07-2012

The European Medicines Agency has been formally notified by US health care giant Johnson & Johnson's…

EuropeJanssen-CilagJohnson & JohnsonOncologyPharmaceuticalRegulationVelcade

Ferring Pharma gains rights for elobixibat from Albireo

05-07-2012

Swiss drugmaker Ferring Pharmaceuticals has entered into a licensing agreement with Albireo AB, a Sweden-based…

AlbireoBiotechnologyelobixibatFerring PharmaceuticalsGastro-intestinalsLicensingPharmaceutical

News briefs from Merck KGaA and Sanofi

05-07-2012

German drug major Merck KGaA )MRK: DE) revealed this morning that its Phase III EXPAND trial, which assessed…

cilengitideErbituxManagementMerck KGaAMergers & AcquisitionsPharmaceuticalResearchSanofi

4% growth forecast for generic drugs market in Central Europe between 2012 and 2014

04-07-2012

According to Polish market research firm PMR's report, titled generic and innovative drugs market in…

EuropeGenericsMarkets & MarketingPatentsPharmaceutical

Slow-down of European bipolar therapy market set for short-term slowdown

04-07-2012

Patent expiry of key blockbuster atypical antipsychotic drugs is likely to cause a decline in growth…

AstraZenecaEuropeGenericsMarkets & MarketingNeurologicalPatentsPharmaceuticalPricingSeroquel

6626 to 6650 of 7218 results

Back to top